Related Experiment Video
Updated: Apr 16, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
13.1K
DHEA replacement for postmenopausal women: placebo or panacea?
1Associate Professor of Reproductive Endocrinology, University of New South Wales ; Director, Women's Health and Research Institute of Australia ; Head, Barbara Gross Research Unit, Royal Hospital for Women , Sydney , Australia.
Summary
Oral dehydroepiandrosterone (DHEA) supplements show no health benefits for postmenopausal women. However, vaginal DHEA may offer a potential therapeutic role, warranting further investigation for hormone therapy.
Area of Science:
- Endocrinology and Hormone Therapy
- Gerontology and Aging Research
Background:
- Dehydroepiandrosterone (DHEA) is the most abundant serum steroid in adults, decreasing with age.
- DHEA functions as a pro-hormone, convertible to androgens and estrogens in peripheral tissues.
- Oral DHEA is marketed as an anti-aging supplement, despite limited clinical evidence.
Discussion:
- Clinical trials and reviews indicate a lack of health benefits from oral DHEA in postmenopausal women.
- The efficacy and safety of oral DHEA supplementation for general anti-aging purposes remain unsubstantiated.
- Investigating alternative delivery methods for DHEA is warranted.
Key Insights:
- Oral DHEA supplementation has not demonstrated significant health benefits for postmenopausal women.
- The pro-hormone status of DHEA and its age-related decline are well-established.
- Vaginal administration of DHEA presents a potential therapeutic avenue.
Outlook:
- Further research is needed to explore the specific role and efficacy of vaginal DHEA.
- Understanding the tissue-specific conversion and action of DHEA may refine its therapeutic applications.
- Future studies should focus on targeted DHEA delivery systems for specific health conditions.
More Related Videos
Related Concept Videos
01:28Menopause
5.2K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.2K
01:22Hormonal Regulation of the Menstrual Cycle
2.5K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.5K
01:16Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
01:40Hormonal Regulation
51.0K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
51.0K
01:33Hormonal Regulation
37.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.4K
01:30Hormonal Control of the Ovarian Cycle
7.8K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.8K